Eckert & Ziegler (ISIN DE0005659700, SDAX) and Ablaze Pharmaceuticals (Ablaze)signed a comprehensive supply agreement for non-carrier added Lutetium-177 (n.c.a. 177Lu). Eckert & Ziegler will serve as the supplier for Ablaze’s clinical trial and…
As the Berlin-based company KNAUER announced on October 12, it is one of the most attractive employers in Germany according to a recent meta-study (top 1% of more than 74,000 employers surveyed).
To further intensify their cooperation, Charité – Universitätsmedizin Berlin has signed a Memorandum Of Understanding (MOU) with Karolinska Institutet and Karolinska University Hospital in Stockholm, Sweden. Going forward, both institutions plan to…
A data gap that threatens timely diagnosis and treatment for half the population, the visibility of female researchers in Wikipedia, and myriads of microbes in and on our bodies – the Max Delbrück Center's program for the Berlin Science Week 2023 is…
Campus Berlin-Buch has a new start-up center: The BerlinBioCube was ceremonially opened on October 11, 2023 in the presence of the Governing Mayor.
Continuation of its European growth course – Expansion of the services for pharmaceutical companies in Europe
One shot in the arm, and the whole body is protected. But how? For one thing, the immune system produces antibodies and cells that patrol the entire organism by traveling through the bloodstream. For another, as shown by a recent Charité –…
New plant will supply cell therapy products for late-stage clinical trials and future product launches / Supports clinical studies with BlueRock Therapeutics’ investigational cell therapy for Parkinson’s Disease bemdaneprocel (BRT-DA01) / New…
Berlin, Singapore, Allschwil 9-29-2023
Prof. Dr. Lars Schaade is the new President of the Robert Koch Institute. The 57-year-old physician had already been acting head of the Institute since 1 April, 2023.
